What problem does it solve?
This Skill streamlines first-pass screening for China small-molecule crystal-form patent expiry opportunities, replacing repetitive manual patent and drug evidence checks with a repeatable workflow.
Core Features & Use Cases
- Live screening workflow: Queries configured Zhihuiya and PatSnap MCP services to find crystal-form patents, verify drug evidence, and separate promoted candidates from excluded records.
- Report generation: Produces a standalone interactive HTML report or a seeded local screening page with tables, notes, sources, export actions, and a value-highlight modal.
- Scope control: Keeps V1 focused on CN small-molecule chemical drugs and crystal-form patents, using compound patent expiry only as supporting evidence.
- Use case: An analyst can ask for a V1 screening run and receive a browser-openable report that is already populated with first-pass results for review and sharing.
Quick Start
Ask this Skill to run a V1 generic-drug opportunity screening for China small-molecule crystal-form patents and generate the local HTML report.